Search for Clinical Trial Results
Sezary Syndrome - 21 Studies Found
Status | Study |
Completed |
Study Name: Tretinoin in Treating Patients With Mycosis Fungoides or Sezary Syndrome Condition: Lymphoma Date: 1999-11-01 Interventions: Drug: tretinoin |
Terminated |
Study Name: Interleukin-2 in Treating Patients With Mycosis Fungoides or Sezary Syndrome Condition: Lymphoma Date: 2000-06-02 Interventions: Biological: aldesleukin |
Active, not recruiting |
Study Name: Alemtuzumab in Treating Patients With Relapsed or Refractory Advanced Mycosis Fungoides or Sézary Syndrome Condition: Lymphoma Date: 2003-04-07 Interventions: Biological: alemtuzumab Will be administered as a two-hour IV infusion with a target dose of 30 milligra |
Recruiting |
Study Name: ID Of Prognostic Factors In Mycosis Fungoides/Sezary Syndrome Condition:
Date: 2016-07-25 |
Completed |
Study Name: Killer Immunoglobulin-Like Receptor Transcripts Expression for the Diagnosis of Epidermotropic Cutaneous T Cell Lymphoma Condition:
|
Recruiting |
Study Name: Tissue Repository: CTCL Collection Protocol Condition:
|
Active, not recruiting |
Study Name: Lenalidomide in Treating Patients With Relapsed Mycosis Fungoides/Sezary Syndrome Condition: Lymphoma Date: 2007-04-25 Interventions: Drug: lenalidomide 10 mg daily orally administered on days 1 - 21 followed by 7 days rest of a 28-day cy |
Completed |
Study Name: Effect of Denileukin Diftitox on Immune System in CTCL Patients Condition:
|